2-232747873-C-A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001103146.3(GIGYF2):​c.171+129C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0663 in 868,698 control chromosomes in the GnomAD database, including 2,393 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.078 ( 598 hom., cov: 33)
Exomes 𝑓: 0.064 ( 1795 hom. )

Consequence

GIGYF2
NM_001103146.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.195

Publications

3 publications found
Variant links:
Genes affected
GIGYF2 (HGNC:11960): (GRB10 interacting GYF protein 2) This gene contains CAG trinucleotide repeats and encodes a protein containing several stretches of polyglutamine residues. The encoded protein may be involved in the regulation of tyrosine kinase receptor signaling. This gene is located in a chromosomal region that was genetically linked to Parkinson disease type 11, and mutations in this gene were thought to be causative for this disease. However, more recent studies in different populations have been unable to replicate this association. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]
GIGYF2 Gene-Disease associations (from GenCC):
  • Parkinson disease 11, autosomal dominant, susceptibility to
    Inheritance: AD, Unknown Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 2-232747873-C-A is Benign according to our data. Variant chr2-232747873-C-A is described in ClinVar as [Benign]. Clinvar id is 1222110.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.165 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GIGYF2NM_001103146.3 linkc.171+129C>A intron_variant Intron 4 of 28 ENST00000373563.9 NP_001096616.1 Q6Y7W6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GIGYF2ENST00000373563.9 linkc.171+129C>A intron_variant Intron 4 of 28 1 NM_001103146.3 ENSP00000362664.5 Q6Y7W6-1

Frequencies

GnomAD3 genomes
AF:
0.0783
AC:
11913
AN:
152088
Hom.:
596
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.117
Gnomad AMI
AF:
0.108
Gnomad AMR
AF:
0.0494
Gnomad ASJ
AF:
0.0167
Gnomad EAS
AF:
0.175
Gnomad SAS
AF:
0.0699
Gnomad FIN
AF:
0.0789
Gnomad MID
AF:
0.0223
Gnomad NFE
AF:
0.0577
Gnomad OTH
AF:
0.0674
GnomAD4 exome
AF:
0.0637
AC:
45626
AN:
716490
Hom.:
1795
AF XY:
0.0630
AC XY:
23735
AN XY:
376680
show subpopulations
African (AFR)
AF:
0.118
AC:
2182
AN:
18560
American (AMR)
AF:
0.0466
AC:
1613
AN:
34604
Ashkenazi Jewish (ASJ)
AF:
0.0192
AC:
377
AN:
19628
East Asian (EAS)
AF:
0.169
AC:
5483
AN:
32414
South Asian (SAS)
AF:
0.0597
AC:
3773
AN:
63250
European-Finnish (FIN)
AF:
0.0779
AC:
2673
AN:
34332
Middle Eastern (MID)
AF:
0.0244
AC:
64
AN:
2622
European-Non Finnish (NFE)
AF:
0.0570
AC:
27083
AN:
475528
Other (OTH)
AF:
0.0669
AC:
2378
AN:
35552
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
2200
4400
6600
8800
11000
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
634
1268
1902
2536
3170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0784
AC:
11929
AN:
152208
Hom.:
598
Cov.:
33
AF XY:
0.0798
AC XY:
5942
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.117
AC:
4870
AN:
41534
American (AMR)
AF:
0.0493
AC:
755
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0167
AC:
58
AN:
3468
East Asian (EAS)
AF:
0.175
AC:
906
AN:
5180
South Asian (SAS)
AF:
0.0695
AC:
335
AN:
4820
European-Finnish (FIN)
AF:
0.0789
AC:
835
AN:
10580
Middle Eastern (MID)
AF:
0.0240
AC:
7
AN:
292
European-Non Finnish (NFE)
AF:
0.0577
AC:
3923
AN:
68004
Other (OTH)
AF:
0.0672
AC:
142
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
552
1104
1655
2207
2759
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
142
284
426
568
710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0577
Hom.:
269
Bravo
AF:
0.0801
Asia WGS
AF:
0.0990
AC:
345
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 20, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.37
DANN
Benign
0.78
PhyloP100
-0.20
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3817310; hg19: chr2-233612583; API